Corcept Therapeutics Inc (CORT)
22.80
+0.59
(+2.66%)
USD |
NASDAQ |
Apr 26, 16:00
22.81
+0.01
(+0.04%)
After-Hours: 20:00
Corcept Therapeutics Gross Profit (Quarterly): 133.53M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 133.53M |
September 30, 2023 | 121.96M |
June 30, 2023 | 116.14M |
March 31, 2023 | 104.27M |
December 31, 2022 | 101.58M |
September 30, 2022 | 100.39M |
June 30, 2022 | 102.07M |
March 31, 2022 | 92.44M |
December 31, 2021 | 97.47M |
September 30, 2021 | 94.86M |
June 30, 2021 | 90.20M |
March 31, 2021 | 78.17M |
December 31, 2020 | 84.48M |
September 30, 2020 | 85.11M |
June 30, 2020 | 87.33M |
March 31, 2020 | 91.37M |
December 31, 2019 | 86.46M |
September 30, 2019 | 80.05M |
June 30, 2019 | 70.88M |
March 31, 2019 | 63.59M |
December 31, 2018 | 65.25M |
September 30, 2018 | 63.14M |
June 30, 2018 | 61.16M |
March 31, 2018 | 56.48M |
December 31, 2017 | 52.12M |
Date | Value |
---|---|
September 30, 2017 | 41.79M |
June 30, 2017 | 34.78M |
March 31, 2017 | 26.95M |
December 31, 2016 | 23.25M |
September 30, 2016 | 21.06M |
June 30, 2016 | 19.30M |
March 31, 2016 | 15.66M |
December 31, 2015 | 14.60M |
September 30, 2015 | 13.00M |
June 30, 2015 | 11.52M |
March 31, 2015 | 9.80M |
December 31, 2014 | 8.756M |
September 30, 2014 | 7.047M |
June 30, 2014 | 5.636M |
March 31, 2014 | 4.231M |
December 31, 2013 | 4.054M |
September 30, 2013 | 2.594M |
June 30, 2013 | 1.868M |
March 31, 2013 | 1.697M |
December 31, 2012 | 1.358M |
September 30, 2012 | 1.031M |
June 30, 2012 | 0.827M |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
70.88M
Minimum
Jun 2019
133.53M
Maximum
Dec 2023
95.72M
Average
92.44M
Median
Mar 2022
Gross Profit (Quarterly) Benchmarks
Ultragenyx Pharmaceutical Inc | 115.34M |
Alnylam Pharmaceuticals Inc | 353.86M |
Catalyst Pharmaceuticals Inc | 94.76M |
United Therapeutics Corp | 543.70M |
XOMA Corp | -- |